Soon, ‘magic pill’ that will allow people to live beyond 100

London, May 11 (ANI): Scientists are developing a new pill, which, if taken at 40, could boost a person’s chances of living longer.

Prof Nir Barzilai, director of the Institute of Ageing at the Albert Einstein College of Medicine in New York, said that one can go on to live for 100 years despite following a poor diet and even smoking, only if their genes are programmed for longevity.

Those who lived very long lives were genetically programmed to do so, which insulated them from the effects of “environmental” factors like smoking and a poor diet.

The professor studied 500 Jewish people between 95 and 112.

“These people smoked, they are overweight, they have high cholesterol,” the Telegraph quoted him as saying.

He said about 30 per cent of them were obese, while 30 per cent of them had smoked to the age of 95.

“They are protected from the environment by their genotype,” he said.

Living a healthy life might help most people increase their life expectancy by a few years, but it won’t be of any use for those who wanted to live much longer, he said.

His findings support anecdotal stories of countless people who have lived to a grand old age seemingly in spite of smoking, lack of exercise or a poor diet.

He said that centenarians tended to have genes, which delayed the onset of age-related illnesses like heart disease and Alzheimer”s.

“When they eventually die, they die of the same things that people die of in their 70s or 80s. It”s just that they die 30 years later,” he said.

Identifying these genes opened the doorway to developing longevity drugs, which mimicked their effects, he said.

The researchers have already identified a number of such genes among the centenarians.

Laboratories are now working on creating a drug which mimics the effects of three of them – two that increase the production of so-called ”good” cholesterol in the body, which reduces the risk of heart disease and stroke, and a third that helps prevent diabetes.

Barzilai said that testing could begin by 2012, with it appearing on the market “within five or 10 years”.

“People will take a pill, starting at 40, and their lives will be longer,” he predicted.

Barzilai will address the Royal Society in London on the subject of ”interfering with ageing to treat ageing-related disease”. (ANI)

Spouses of dementia sufferers ‘six times more likely to develop same condition’

Washington, May 5 (ANI): Spouses of dementia sufferers are six times more likely to develop the condition themselves, compared to similar older married adults whose partner never develops dementia, according to a new study.

The study has been published in the Journal of the American Geriatrics Society.

Informal dementia caregiving for a spouse is a natural marital obligation, and spousal caregivers often report positive feelings toward caregiving, yet it is difficult, requiring time, energy and usually physical exertion. Dementia caregivers have been shown to provide more assistance, and to report more personal sacrifices and stress, than those who care for physically-impaired elderly without dementia. While there are many published studies showing that dementia caregivers are at higher risk for health problems and depression, none have examined risk for dementia in the caregiver.

For the research, 2,442 subjects (1,221 married couples) aged 65 and older from Northern Utah, USA, without dementia at onset were studied for up to 12 years to monitor for onset of dementia in husbands, wives or both. During this time, 125 cases of dementia only in the husband were diagnosed, 70 only in the wife, and 30 where both spouses were diagnosed (60 people).

The researchers, led by Dr. Maria Norton of Utah State University, USA, adjusted for socioeconomic status, a significant predictor of many health-related outcomes including dementia to control for shared environmental exposures that might influence risk for dementia in both spouses.

The results showed that incident dementia was significantly associated with older age, and having a spouse with dementia. Participants with a spouse who developed dementia were at a six times increased risk of developing dementia, net of the effect of age, gender, APOE genotype, and socioeconomic status, with higher risk in men (11.9) than women (3.7).

“Future studies are needed to determine how much of this association is due to caregiver stress compared to a shared environment,” said Norton. “On the positive side, the majority of these individuals, with spouses who develop dementia, did not themselves develop dementia, therefore more research is needed to explore which factors distinguish those who are more vulnerable.”

“Given the significant public health concern of Alzheimer”s disease and other dementias, and the upcoming shift in population age composition, continued research into the causes of dementia is urgent,” concluded Norton. (ANI)

Gene variant could protect memory and thinking skills in older people

Washington, Apr 20 (ANI): A gene variant could help protect the memory and thinking skills of older people, according to a new research.

For the study, researchers followed 2,858 African-American and Caucasian people between the ages of 70 and 79 for eight years.

Participants” DNA was analysed for the catechol-O-methyltransferase (COMT) gene, a gene shown in studies to affect thinking skills.

The allelic variants associated with this gene are the Val and Met variants.

“This is the first study to identify a protective relationship between this gene variant and cognitive function,” said study author Dr. Alexandra Fiocco, with the University of California, San Francisco.

The group was also given two types of thinking tests. One test measured skills such as language, concentration and memory.

The other test measured response time, attention and judging sights and objects.

The study found that the Met variant of the COMT gene was linked to a greater decline in thinking skills over the years, while the Val variant had a protective effect on thinking skills, with lower declines over the years.

In Caucasians, those with the Val variant scored 33 percent better over time than those without the variant. Among African-Americans, people with the Val allele gene variant scored 45 percent better over time than those who did not have the variant.

“This finding is interesting because in younger people, the Val genotype has been shown to have a detrimental effect. But in our study of older people, the reverse was true. Finding connections between this gene, its variants and cognitive function may help scientists find new treatments for the prevention of cognitive decline,” said Fiocco.

However, he added that the results need to be replicated by others before the field can be confident that the Met variant of the COMT gene plays a role in late life cognitive decline.

The research will be published in the latest issue of Neurology, the medical journal of the American Academy of Neurology. (ANI)

Can an individual’s bitter-taste sensitivity help determine diabetes risk?

Washington, July 11 (ANI): A research team at Kansas State University, including an Indian origin scientist, are studying whether an individual’s bitterness sensitivity can help predict his/her risk of developing type 2 diabetes.

Lead researcher Kathy Nguyen, senior in public health nutrition along with colleagues Koushik Adhikari and Mark Haub, are studying the genotypes of diabetic and non-diabetic individuals to determine the possible link.

For the study, Nguyen is collecting cheek cell samples from about 60 men and women between the ages of 40 and 70. The sample includes people with and without type 2 diabetes.

The researchers will later genotype two variations within a DNA sequence to determine whether the individuals are supertasters, tasters or non-tasters of bitterness.

Supertasters are more sensitive to bitterness than tasters, and non-tasters are not sensitive.

The team hopes that by understanding whether bitterness sensitivity is linked to type 2 diabetes, there is a potential to screen individuals for bitterness sensitivity, and to use that information as a predictive marker for the disease and other chronic disease such as heart disease and obesity.

“This is a preliminary stage with a small sample size,” Adhikari said.

“The study has to be repeated with a larger population of different ethnicities to arrive at any meaningful conclusions. However, Kathy will establish the protocol for this project,” he added. (ANI)

Scientists use genetic engineering to make virus-resistant grapevines

Washington, July 3 (ANI): Scientists are making certain plants resistant to the “Grapevine fanleaf virus” GFLV by genetic engineering.

Extremely hot or rainy periods can destroy entire crops, not to mention the wide variety of pests that can appear on the scene.

Bugs such as the vine louse or the rust mite, fungi such as mildew, or viruses such as the GFLV can give the vines a hard time.
he GFLV infects the grapevine and causes fanleaf disease, resulting in deformed and very yellowed leaves, smaller grapes and crop loss.

Now, with the help of genetic engineering, researchers at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen in Germany, are making certain plants resistant to GFLV.

“Our modified plants produce antibodies,” explained Dr. Stefan Schillberg, head of department at the IME. “These antibodies ‘recognize’ the viruses and prevent them from spreading in the plant and causing damage,” she added.

To enable the plant to produce the antibodies, the scientists have to modify its genotype and channel genetic information for the antibodies into it.

This task is performed by tiny helpers called agrobacteria, which genetic engineers have been using for over twenty years.

These are soil bacteria that inherently transfer parts of their own genome to that of the plant.

Using simple routine processes, the researchers introduce the antibody gene into the bacteria, which then act as a transport vehicle and carry it over to the vine.

The researchers are still testing this process on model plants, and the first results show that their modified versions are up to 100 percent resistant to the virus.
“The antibody is produced very effectively inside the plants,” said Schillberg. “The next step on the agenda is to test the method on actual grapevines and then to carry out field tests,” he added. (ANI)

‘DNA Sudoku’ to revolutionise genome sequencing, medical genetics

Washington, June 25 (ANI): Sudoku, the popular mathematics puzzle that has taken people by storm, is now set to revolutionize the world of genome sequencing and the field of medical genetics, according to a new study.

Researchers at Cold Spring Harbor Laboratory (CSHL) have combined 2,000-year-old Chinese math theorem with concepts from cryptologyto develop what they dubbed as the “DNA Sudoku”, because of its similarity to the logic and combinatorial number-placement rules used in the popular game.

The strategy allows tens of thousands of DNA samples to be combined, and their sequences – the order in which the letters of the DNA alphabet (A, T, G, and C) line up in the genome – to be determined all at once.

The accomplishment is quiet contrary to past approaches that allowed only a single DNA sample to be sequenced at a time.

It also has an upper hand on current approaches that, at best, can combine hundreds of samples for sequencing.

“In theory, it is possible to use the Sudoku method to sequence more than a hundred thousand DNA samples,” said CSHL Professor Gregory Hannon, leader of the team that invented the “Sudoku” approach.

With such efficiency, the approach promises to reduce costs dramatically.

The new method has tremendous potential for clinical applications. It can be used, for example to analyse specific regions of the genomes of a large population and identify individuals who carry mutations that cause genetic diseases – a process known as genotyping.

The key to the team’s innovation is the pooling strategy, which is based on the 2,000-year-old Chinese remainder theorem.

The method is currently best suited for genotype analyses that require only short segments of an individual’s genome to be sequenced to find out if the individual is carrying a certain variant of a gene or a rare mutation.

However, with the improvement in sequencing technologies and researchers gaining the ability to generate sequences for longer segments of the genome, Hannon envisions wider clinical applications for their method such as HLA typing, already an important diagnostic tool for autoimmune diseases, cancer, and for predicting the risk of organ transplantation.

The report will be published as the cover story in the July 1 issue of the journal Genome Research.(ANI)

Kids’ susceptibility to pesticides’ toxic effects extends much longer into childhood than expected

Washington, June 24 (ANI): The risk of toxic effects of pesticides on kids extends much longer into childhood than expected, reveals a new study at the University of California, Berkeley.

Newborns’ levels of an enzyme called paraoxonase 1 (PON1), critical to the detoxification of organophosphate pesticides, average one-third or less than those of the babies’ mothers.

It was earlier believed that PON1 enzyme activity in children approaches adult levels by age 2.

But the researchers have now found that the enzyme level remains low in some individuals through age 7.

On the basis of their findings, the researchers have recommended that the U.S. Environmental Protection Agency (EPA) re-evaluate the current standards for acceptable levels of pesticide exposure.

“Current EPA standards of exposure for some pesticides assume children are 3 to 5 times more susceptible than adults, and for other pesticides the standards assume no difference,” said Nina Holland, UC Berkeley adjunct professor of environmental health sciences and senior author of the paper.

She added: “Our study is the first to show quantitatively that young children may be more susceptible to certain organophosphate pesticides up to age 7. Our results suggest that the EPA standards need to be re-examined to determine if they are adequately protecting the most vulnerable members of the population.”

The study involved 458 children from an agricultural region who were followed from birth through age 7.

Cord blood samples were collected from all children to determine their PON1 genotype and to obtain baseline measures of the enzyme’s activity level.

The researchers observed that on an average the quantity of enzyme quadrupled between birth and age 7.

The study has been published in the journal Environmental Health Perspectives. (ANI)

Genetic risk for anxiety, depression not predestined: Study

Washington, April 30 (ANI): Previous studies have provided a strong basis of support for hypothesis that individuals with particular genotypes are predestined to negative life outcomes such as depression, anxiety disorders. But now, a new study has challenged this view.

Researchers studied infant monkeys from four different rearing conditions to examine how social context and different forms of early adversity interact with genotype to influence behaviour.

Animals reared in small social groups were more likely to be aggressive and anxious, particularly among those with a low activity MAOA genotype.

However, no genotype effects were evident in monkeys reared in larger social cages.

There are some circumstances in a child’s development – such as abusive parenting – that everyone would agree constitutes “adversity.”

However, this study suggests that other, subtler features of the broader social environment influence development, and that genes that affect our behavioral responses are sensitive to these influences.

So even though an infant may be reared with its nurturing mother, the relative absence of other social partners, for both the mother and the infant, can result in the infant developing an anxious style of responding to challenges, particularly if it possesses a “risky” genotype.

Of particular significance, said senior author John Capitanio, Ph.D., is “that animals that were raised in rich, complex settings with mothers, other kin, and peers, were completely protected from the potentially deleterious effects of having the ‘risky’ form of the MAOA gene.”

The study is published in the May 1st issue of Biological Psychiatry. (ANI)

Migraine, stroke and heart attacks may be genetically linked

Washington, February 17 (ANI): A group of American scientists have set out to determine whether a gene variant may affect the link between migraine and stroke or heart attacks.

Dr. Markus Schurks, of the Division of Preventive Medicine at Brigham and Women’s Hospital in Boston, revealed that the study on 25,000 women look at the genetic variant called the angiotensin-converting enzyme (ACE) D/I polymorphism.

The study’s author said that the women answered a questionnaire about their history of migraines and migraines with aura.

Aura is usually described as visual disturbances like flashing lights or geometric patterns, according to background information in a research article published in the medical journal of the American Academy of Neurology.

A total of 4,577 women reported a history of migraine and of those, 1,275 had migraine with aura.

Schurks said that 625 strokes and heart attacks were reported 12 years after the start of the study.

The study did not find a link between the gene variant and migraine, migraine with aura, stroke or heart attacks.

But women who had migraine with aura and also were carriers of certain genotypes, called the DD and the DI genotypes, had double the risk of stroke and heart attacks.

On the other hand, the subjects who had migraine with aura, and were carriers of a third genotype called the II genotype, were not at increased risk.

Schurks cautioned that the relationship was identified with very little information, and must be tested in other studies to determine if it is real.

“The complex relationship among this gene variant, migraine, stroke and heart disease has been the focus of many studies and the results have been controversial. Getting to the bottom of whether there is a connection and why may help to develop ways to prevent issues like stroke and heart disease, which are leading causes of death in the United States,” says the study author. (ANI)

Gene variants associated with an elevated risk of hypertension found

Gene variants associated with an elevated risk of hypertension found Recent study has revealed the first common gene variants associated with an elevated risk of hypertension. Research team led by Christopher Newton-Cheh of the Massachusetts General Hospital’s Center for Human Genetic Research studied the DNA of nearly 30,000 people.

The research team studied variants of two genes for these peptides — atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP). Study showed clear relationship between three variants and higher levels of the peptides and, therefore, to lower blood pressure.

Newton-Cheh said that higher peptide levels lead to lower blood pressure because “these are molecules designed to let the body get rid of salt and relax blood vessels.

He added: “What distinguishes this study is the ability to genotype 30,000 people to establish a relationship that these gene variants cause higher levels of natriuretic peptides and therefore are related to blood pressure.” Natriuretic peptides are compounds that help the body get rid of salt.

He said that the medical implication of the study is that “there are people out there who do not have enough natriuretic peptide, and they can be targeted to increase those peptides.”

Genetic model that predicts how plants respond to climate change

Washington, Jan 18 (ANI): Scientists have created a genetic model that can predict how plants respond to climate change and flower in different environments.

It has been known for some time that plants respond to environmental cues that guide their flowering.

Chief among these signals are light, temperature and vernalization, when flowering is promoted by prolonged exposure to cold temperatures.

In some plants, scientists have identified particular genes that deal with each of these environmental signals. But, they haven’t fully grasped how plants integrate these signals in nature.

Through a series of field experiments at five European sites, a Brown University-led research team has charted the internal and external signals that guide the life cycle of one plant species, Arabidopsis thaliana, across its native climate range.

The team has created a model that shows the importance of the genetic and environmental cues for key genotypes of Arabidopsis and how these signals vary depending on the plant’s location and seasonal environment.

“This is a powerful tool to predict how this plant species and other species will respond to climate change and which genetic pathways are important in different environments,” said Amity Wilczek, a postdoctoral research associate in ecology and evolutionary biology at Brown and the paper’s lead author.

The seesaw competition of genetic pathways inside the plant goes on until a threshold is reached, a molecular switch that triggers the plant to cross into the next stage of development.

By examining mutants impaired in different genes, the research team could quantify shifts in the balance of this seesaw across different seasons and climates.

The team discovered that certain mutations with major effects under laboratory conditions had variable and sometimes unexpectedly small effects in natural field environments.

Wilczek and Schmitt, along with Stephen Welch, a professor in the agronomy department at Kansas State University, then created models that charted precisely the rates of development for the genotypes at the field sites, using hourly temperature and light data collected at each site.

They showed when each genotype would reach its threshold and switch from a vegetative state to a flowering stage.

The models also accurately predicted the contribution of each genetic pathway to development and how the pathways are affected by environmental cues.

“With our model, we have shown that we can successfully predict how flowering is going to behave under a range of environmental conditions, not just those in which we originally grew our plants,” Wilczek said.

“Given the changing climate and the importance of flowering timing for wild plants and crop plants, this model can help us better understand how plants will respond to future conditions,” he added. (ANI)

Gene linked to reduced mortality from acute lung Injury identified

Washington, Jan 17 (ANI): Researchers at National Jewish Health and the University of Colorado Denver have identified a gene linked to improved survival among patients with acute lung injury.

Acute lung injury (ALI) is often caused by a respiratory infection and results in low oxygen levels in the blood, and fluid in the lungs.

“This discovery could benefit patients in two ways,” said James Crapo. MD, senior author and Professor of Medicine at National Jewish Health.

“By learning how this specific gene can alter the course of acute lung injury, we can gain insight into the biology of the disease, which could lead to better therapies.

“It also could become a tool in personalized medicine; by screening for this protective genotype and ones that make a person more susceptible to ALI, we can potentially tailor our treatment individual patients with respiratory infections and ALI to minimize the potential harm,” he added.

During the study, the researchers looked at the gene for extracellular superoxide dismutase (EC-SOD), a powerful antioxidant that has been associated with reduced lung injury in animal models, and better patient outcomes in chronic obstructive pulmonary disease.

The researchers then looked at the various forms of the EC-SOD gene in two groups of patients with infection-associated ALI.

They found that patients with a specific combination of four single nucleotide polymorphisms (SNPs), had an 75 percent reduced risk of being on a ventilator as all other ALI patients, and an 85 percent reduced risk of dying.

“This specific set of SNPs, which we call the GCCT haplotype, appears to reduce inflammation in the lung, thereby decreasing the severity of lung injury and ultimately protecting patients from mortality associated with ALI,” said John J. Arcaroli, PhD, first author and a post-doctoral fellow at the University of Colorado at Denver.

“Although We are not yet sure how these particular SNPs alter the action of the EC-SOD, these findings gives us a good starting point to learn more about possible protective mechanisms in ALI and other lung diseases,” he added.

The study appears in American Journal of Respiratory and Critical Care Medicine. (ANI)